Retrospective cohort study evaluates improved clinical outcomes in IVF cycles with protocol changes, suggesting personalized treatments.
Objective: To evaluate whether a protocol modification or not between a first and second IVF cycle was associated with improved clinical outcomes. Design: A retrospective longitudinal cohort study of patient charts that compared first and second IVF cycles. Materials and Methods: A total of 259 patients who underwent two consecutive IVF cycles between Jan 1, 2020 and Dec 31, 2025 were included in this study. Patients (n=213) who had a stimulation protocol assessment and chart review resulting in a treatment change (Change) were compared with a cohort (n=46) who underwent repeat IVF cycles without any change (No Change) in stimulation protocol. Cycle outcomes included: # of oocytes retrieved, fertilization rate, # of blastocysts, and blastocyst utilization rate (BUR). Descriptive statistics were calculated as means ± standard deviation. First- and second-cycle outcomes were compared using t-tests, with p < 0.05 considered statistically significant. Results: Mean patient age were similar between cycles and groups. Following protocol modification, the mean number of oocytes retrieved increased significantly from 9.45 ± 5.94 to 11.19 ± 6.71 (p=0.005), representing an 18.4% improvement in oocyte yield. Although not statistically significant (p=0.134), fertilization rate increased slightly from 53.2 ± 25.0% to 56.8 ± 23.6%. Mean blastocyst yield improved over 50% from 1.92 ± 1.90 to 2.89 ± 2.77 (p<0.001). BUR also increased significantly from 34.0 ± 28.1% to 41.2 ± 28.6% (p=0.012) in a cycle after a protocol change. In contrast, no clinical outcome improvement(s) were observed among patients in the No Change Group. Conclusions: This study demonstrates the benefit of protocol modification for a second ovarian stimulation cycle. These findings support reassessing and personalizing stimulation strategies after an initial IVF response to optimize subsequent cycle outcomes and treatment efficiency.
No takes yet. Share an insight, caveat, or question.
Shirani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: